6 Results for "

Hyperinsulinism

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "Hyperinsulinism" in MCE Product Catalog:

10
10 Cited Publications
Cat. No.: HY-B1140
CAS No.: 364-98-7
Synonyms: Sch-6783; SRG-95213
Research Areas:  

Cardiovascular Disease Cancer

Diazoxide (Sch-6783) is an ATP-sensitive potassium channel activator, has the potential for hyperinsulinism treatment.
loading...
    loading...
Cat. No.: HY-B1140R
CAS No.: 364-98-7
Synonyms: Sch-6783 (Standard); SRG-95213 (Standard)
Diazoxide (Standard) is the analytical standard of Diazoxide. This product is intended for research and analytical applications. Diazoxide (Sch-6783) is an ATP-sensitive potassium channel activator, has the potential for hyperinsulinism treatment.
loading...
    loading...
Cat. No.: HY-169249
Synonyms: Z1620764636
Target:  

Potassium Channel

Research Areas:  

Metabolic Disease

Aekatperone is a reversible KATP channel inhibitor, with an IC50 of 9 μM. Aekatperone can be used for the research of congenital hyperinsulinism (CHI) .
loading...
    loading...
Cat. No.: HY-176745
CAS No.: 292613-04-8
Target:  

VDAC

Research Areas:  

Metabolic Disease Endocrinology

SW016789 is a hypersecretion-inducer targeting VDAC1. SW016789 can induce insulin hypersecretion and Ca 2+ influx in β-cells directly. SW016789 induces a transient endoplasmic reticulum stress response (ER stress), but does not cause beta cell death. SW016789 has reversible and non-apoptotic characteristics. SW016789 can be used for the study of Diabetes mellitus type 2 (T2DM) β-cell dysfunction .
loading...
    loading...
Cat. No.: HY-B1140S
CAS No.: 1432063-51-8
Synonyms: Sch-6783-d3; SRG-95213-d3
Diazoxide-d3 is deuterium labeled Diazoxide. Diazoxide (Sch-6783) is an ATP-sensitive potassium channel activator, has the potential for hyperinsulinism treatment.
loading...
    loading...
Cat. No.: HY-164040
CAS No.: 2604416-66-0
Target:  

Somatostatin Receptor

Research Areas:  

Metabolic Disease

Zavolosotine (Compound 1) is an orally active agonist for somatostatin receptor type 5 (SST5) with EC50 <1 nM. Zavolosotine inhibits insulin and glucagon secretion, increases levels of glucagon in blood in rat model .
loading...
    loading...